Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VANI | US
-0.02
-1.89%
Healthcare
Biotechnology
30/06/2024
09/04/2026
1.04
1.07
1.07
1.03
Vivani Medical Inc. a clinical stage company develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville California.
View LessHigh Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
83.6%1 month
71.7%3 months
66.6%6 months
69.2%-
-
3.02
0.84
0.42
-3.93
-
-
-24.90M
57.47M
57.47M
-
-
-
-
-86.10
8.90
2.98
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.20
Range1M
0.34
Range3M
0.65
Rel. volume
0.20
Price X volume
46.17K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| InflaRx N.V | IFRX | Biotechnology | 1.03 | 60.65M | 8.42% | n/a | 0.00% |
| Aptevo Therapeutics Inc | APVO | Biotechnology | 4.37 | 58.74M | 2.10% | n/a | 112.59% |
| ImmuCell Corporation | ICCC | Biotechnology | 7.19 | 56.32M | 12.70% | n/a | 67.52% |
| THL Credit Inc. 6.75% Notes du | TCRX | Biotechnology | 1.06 | 56.15M | 0.00% | n/a | 35.68% |
| CDIO | CDIO | Biotechnology | 1.81 | 55.39M | -10.84% | n/a | 28.31% |
| Sangamo Therapeutics Inc | SGMO | Biotechnology | 0.2619 | 54.53M | 2.83% | n/a | 122.82% |
| OKYO Pharma Limited | OKYO | Biotechnology | 1.58 | 53.46M | -0.63% | n/a | -107.88% |
| PEPG | PEPG | Biotechnology | 1.61 | 52.47M | -3.01% | n/a | 12.52% |
| Tenax Therapeutics Inc | TENX | Biotechnology | 14.96 | 51.00M | -0.60% | n/a | 3.14% |
| Clene Nanomedicine Inc | CLNN | Biotechnology | 6.34 | 50.48M | -0.94% | n/a | -6472.02% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.16 | 16.95M | -4.13% | 0.03 | 16.03% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 11.02 | 16.78M | 94.36% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.651 | 12.58M | -0.82% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3 | 3.32M | 2.85% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2987 | 2.84M | 10.96% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.95 | 1.07M | -3.47% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.93 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.02 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 66.63 | - | Par |
| Debt to Equity | 0.84 | -1.23 | Expensive |
| Debt to Assets | 0.42 | 0.25 | Expensive |
| Market Cap | 57.47M | - | Emerging |